Similar articles

• Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.

  Ferguson SG, Gitchell JG, Shiffman S, Sembower MA. Ferguson SG, et al. Clin Ther. 2009 Sep;31(9):1957-65. doi: 10.1016/j.clinthera.2009.08.029. Clin Ther. 2009. PMID: 19843485
• Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study.

  Vieregge A, Sieberer M, Jacobs H, Hagenah JM, Vieregge P. Vieregge A, et al. Neurology. 2001 Sep 25;57(6):1032-5. doi: 10.1212/wnl.57.6.1032. Neurology. 2001. PMID: 11571330 Clinical Trial.
• Transdermal nicotine for induction of remission in ulcerative colitis.

  McGrath J, McDonald JW, Macdonald JK. McGrath J, et al. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004722. doi: 10.1002/14651858.CD004722.pub2. Cochrane Database Syst Rev. 2004. PMID: 15495126 Review.
• Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.

  Lemay S, Chouinard S, Blanchet P, Masson H, Soland V, Beuter A, Bédard MA. Lemay S, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):31-9. doi: 10.1016/S0278-5846(03)00172-6. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 14687854 Clinical Trial.
• [Transdermal nicotine treatment of ulcerative colitis: a survey of a Cochrane review].

  Seidelin JB, Nielsen OH. Seidelin JB, et al. Ugeskr Laeger. 2006 Feb 13;168(7):674-7. Ugeskr Laeger. 2006. PMID: 16494804 Review. Danish. No abstract available.